Table_1_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

“…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”

Table_2_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

“…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”

Table_10_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

“…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”

Image_1_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

“…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”

Table_8_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

“…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”

Presentation_1_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

“…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”

Table_4_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

“…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”

Table_3_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

“…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”

Table_1_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.XLSX by André Weigert (7888712)

“…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”

Table_9_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

“…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”

Table_13_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

“…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”

Table_12_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

“…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”

Table_6_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

“…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”

Table_11_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

“…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”

Plasma levels of isoprostane and 3-nitrotyrosine in animals treated with AEOL. by Devi Ganesh (3176385)

ST2+ KLRG-1+ Tregs from <i>T</i>. <i>cruzi</i> infected mice exhibit a phenotype compatible with <i>bona fide</i> trTregs. by Santiago Boccardo (5927954)

The formation of surface-induced intermediate precedes the loss of native subunit conformation. by Jian-Min Lv (5324774)

“…<p>pCRP or mCRP was immobilized onto hydrophilic microtiter wells (Nunc MaxiSorp) for 3 min in TBS-Ca (pH 7.4) at 37°C. After brief washes, the immobilized proteins were further incubated for 0–2 h followed by antigenicity detection with 3H12 (A), 8C10 (B), 8D8 (C) or 1D6 (D). …”

Image_1_Modulation of Immune Response to Chlamydia muridarum by Host miR-135a.pdf by Jonathon Keck (10589153)

“…We report here chlamydial infection results in decreased miR-135a expression in mouse genital tissue and a fibroblast cell line. …”

Model performance compared to experimental data: responses to sustained stimulations of inhibitory neurons within the pre-BötC. by Jessica Ausborn (5147210)

“…Output activity of all neuron populations in the model are shown; the oscillation frequency increases in A, decreases in B, and oscillations are completely suppressed in C, similarly to our experimental studies (<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1006148#pcbi.1006148.g005" target="_blank">Fig 5</a>) (<b>D</b>) Biphasic change in oscillation frequency in the model depending on the stimulation intensity.…”

Heterologous expression of <i>trsA</i> in <i>C. elegans</i> causes severe morphological alterations. by Jennifer Emser (22120206)

“…The nematodes expressing <i><i>trsA</i></i> show a lower survival rate from day 10 on, with a strong decrease after day 13. <b>(D)</b> <i><i>C. elegans</i></i> expressing <i><i>trsA</i></i> under the heat shock promoter <i><i>hsp-16.48</i></i>. …”